bpc-157 human clinical trial evidence safety fda status FDA's Overreach on Compounded Peptides Repost @peptides with @use.repost ・・・

Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA Advisory Panel Votes to Loosen Rules on BPC 157, TB 500, and MOTS C Despite Agency Scientists' Opposition BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY

SKU: 71438568760 · From lagence-mr.com